Literature DB >> 21089112

Soluble receptors for advanced glycation end products (sRAGE) as a predictor of restenosis following percutaneous coronary intervention.

Erick D McNair1, Calvin R Wells, A Mabood Qureshi, Rashpal Basran, Colin Pearce, Jason Orvold, Jacobus Devilliers, Kailash Prasad.   

Abstract

BACKGROUND: Interaction of advanced glycation end products (AGEs) with their receptor (RAGE) increases expression of inflammatory mediators (tumor necrosis factor alpha [TNF-α] and soluble vascular cell adhesion molecule-1 [sVCAM-1]) and induces oxygen radicals that are implicated in atherosclerosis. Balloon-injury-induced atherosclerosis is associated with increased expression of AGEs and RAGE. The soluble receptor for AGE (sRAGE), which acts as a decoy for RAGE ligands (AGEs), prevents atherosclerosis in this model. HYPOTHESIS: We evaluated: 1) whether post-percutaneous coronary intervention (PCI) restenosis is associated with low pre-PCI serum sRAGE, high serum AGEs, TNF-α, and sVCAM-1, and high AGE/sRAGE ratio; 2) whether pre-PCI and post-PCI levels of these markers are similar in patients with or without restenosis; and 3) whether sRAGE and AGE/sRAGE ratio have predictive value for post-PCI restenosis.
METHODS: Angiography was performed in 46 patients with non-ST-segment elevation myocardial infarction for assessment of restenosis. Serum sRAGE, AGEs, TNF-α, and sVCAM-1 were measured in these patients and 20 control subjects.
RESULTS: : Nineteen of the 46 patients developed post-PCI restenosis, which was associated with lower sRAGE and higher TNF-α and sVCAM-1 levels, and higher AGE/sRAGE ratio compared with patients without restenosis. Pre-PCI and post-PCI levels of these biomarkers were similar in both groups, except in patients with restenosis, in whom the post-PCI level of sRAGE was lower and TNF-α was higher than the pre-PCI levels. The sensitivity and negative predictive value of sRAGE were 100%, and were higher than those of AGE/sRAGE ratio in identifying post-PCI restenosis.
CONCLUSIONS: Both low serum sRAGE levels and high AGE/sRAGE ratio have predictive value for post-PCI restenosis.
Copyright © 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21089112      PMCID: PMC6653629          DOI: 10.1002/clc.20815

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  38 in total

1.  RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.

Authors:  M A Hofmann; S Drury; C Fu; W Qu; A Taguchi; Y Lu; C Avila; N Kambham; A Bierhaus; P Nawroth; M F Neurath; T Slattery; D Beach; J McClary; M Nagashima; J Morser; D Stern; A M Schmidt
Journal:  Cell       Date:  1999-06-25       Impact factor: 41.582

2.  Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.

Authors:  Hideto Yonekura; Yasuhiko Yamamoto; Shigeru Sakurai; Ralica G Petrova; Md Joynal Abedin; Hui Li; Kiyoshi Yasui; Masayoshi Takeuchi; Zenji Makita; Shin Takasawa; Hiroshi Okamoto; Takuo Watanabe; Hiroshi Yamamoto
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

Review 3.  The biology of the receptor for advanced glycation end products and its ligands.

Authors:  A M Schmidt; S D Yan; S F Yan; D M Stern
Journal:  Biochim Biophys Acta       Date:  2000-12-20

Review 4.  Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.

Authors:  A M Schmidt; S D Yan; J L Wautier; D Stern
Journal:  Circ Res       Date:  1999-03-19       Impact factor: 17.367

5.  Restenosis after coronary placement of various stent types.

Authors:  A Kastrati; J Mehilli; J Dirschinger; J Pache; K Ulm; H Schühlen; M Seyfarth; C Schmitt; R Blasini; F J Neumann; A Schömig
Journal:  Am J Cardiol       Date:  2001-01-01       Impact factor: 2.778

6.  RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

Authors:  Loredana G Bucciarelli; Thoralf Wendt; Wu Qu; Yan Lu; Evanthia Lalla; Ling Ling Rong; Mouza T Goova; Bernhard Moser; Thomas Kislinger; Daniel C Lee; Yogita Kashyap; David M Stern; Ann Marie Schmidt
Journal:  Circulation       Date:  2002-11-26       Impact factor: 29.690

Review 7.  Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure.

Authors:  Dan Sorescu; Kathy K Griendling
Journal:  Congest Heart Fail       Date:  2002 May-Jun

8.  Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed.

Authors:  K Prasad
Journal:  Circulation       Date:  1999-03-16       Impact factor: 29.690

Review 9.  Atherosclerosis and diabetes: the RAGE connection.

Authors:  A M Schmidt; D Stern
Journal:  Curr Atheroscler Rep       Date:  2000-09       Impact factor: 5.113

Review 10.  Inflammation and atherosclerosis.

Authors:  Peter Libby; Paul M Ridker; Attilio Maseri
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

View more
  22 in total

1.  Racial differences in circulating levels of the soluble receptor for advanced glycation endproducts in middle-aged and older adults.

Authors:  Tina E Brinkley; Xiaoyan Leng; Barbara J Nicklas; Stephen B Kritchevsky; Jingzhong Ding; Dalane W Kitzman; W Gregory Hundley
Journal:  Metabolism       Date:  2017-02-10       Impact factor: 8.694

Review 2.  Soluble RAGEs - Prospects for treating & tracking metabolic and inflammatory disease.

Authors:  Ann Marie Schmidt
Journal:  Vascul Pharmacol       Date:  2015-06-27       Impact factor: 5.773

Review 3.  Role of Advanced Glycation End Products and Its Receptors in the Pathogenesis of Cigarette Smoke-Induced Cardiovascular Disease.

Authors:  Kailash Prasad; Indu Dhar; Gudrun Caspar-Bell
Journal:  Int J Angiol       Date:  2015-06

Review 4.  AGE-RAGE Stress, Stressors, and Antistressors in Health and Disease.

Authors:  Kailash Prasad; Manish Mishra
Journal:  Int J Angiol       Date:  2017-12-28

5.  Advanced Glycation End Products:Receptors for Advanced Glycation End Products Axis in Coronary Stent Restenosis: A Prospective Study.

Authors:  Colin Pearce; Naorin Islam; Robyn Bryce; Erick Donnell McNair
Journal:  Int J Angiol       Date:  2018-10-29

6.  Effects of bone marrow MSCs transfected with sRAGE on the intervention of HMGB1 induced immuno-inflammatory reaction.

Authors:  Jun Wang; Hao Wang; Jiong Shi; Yitao Ding
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

7.  Resveratrol, wine, and atherosclerosis.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2012-03

8.  Pathophysiology and Medical Treatment of Carotid Artery Stenosis.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2015-06-23

9.  Reasons to Investigate the Soluble Receptor for Advanced Glycation End-Product (sRAGE) Pathway in Aortic Disease.

Authors:  Abdullah Sarkar; Kailash Prasad; Bulat A Ziganshin; John A Elefteriades
Journal:  Aorta (Stamford)       Date:  2013-08-01

Review 10.  Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.